News Releases

Results of a preliminary study by scientists at the National Institutes of Health and Johns Hopkins show that "mini" stem cell transplantation may safely reverse severe sickle cell disease in adults.

Several leaders at the Johns Hopkins Avon Foundation Breast Center have issued a statement regarding the new mammography screening guidelines suggested by the United States Preventive Task Force Service.

JOHNS HOPKINS KIMMEL CANCER CENTER TO HOST VOLUNTEER CONCERT FOR PATIENTS & FAMILIES

TOP LOCAL ELECTED OFFICIALS HEADLINE LIST OF CELEBRITY BAGGERS AT SAFEWAY STORES THIS MONTH

The National Cancer Institute (NCI) has awarded $10.4 million to Johns Hopkins and The University of Southern Califonia (USC) to decipher epigenetic marks in the cancer genome.  The joint five-year grant is expected to help scientists develop drugs and tests that target epigenetic changes in cancer cells.

A committee of scientists led by Johns Hopkins investigators has published a new guide to the biology, diagnosis and treatment of lung cancer in never-smokers, fortifying measures for what physicians have long known is a very different disease than in smokers.

The Hedgehog signaling pathway is involved in a preliminary study and case report describing positive responses to an experimental anticancer drug in a majority of people with advanced or metastatic basal cell skin cancers. One patient with the most common type of pediatric brain cancer, medulloblastoma, also showed tumor shrinkage.

Johns Hopkins scientists say they have figured out how bacteria that cause diarrhea may also be the culprit in some colon cancers. The investigators say that strains of the common Bacteroides fragilis (ETBF) dupe immune system cells into permitting runaway colon tissue inflammation, a precursor for malignant growth.

Dietary sugar intake unlikely to have any impact, scientists caution

Donald Small, M.D., Ph.D., a nationally recognized leader in the research and treatment of childhood blood cancers, has been selected to head the Pediatric Oncology Division of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Donates $35,000 to Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center to Support Childhood Cancer Research

Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.

Phase II study showed effects of short-term green tea use on prostate cancer, Green tea reduced incidence, progression of prostate cancer, Right combination of polyphenols can slow prostate cancer growth

A TV industry- and celebrity-driven cancer research project has chosen scientists at Johns Hopkins for two of five multi-institutional “dream teams” financed by “Stand Up to Cancer “ grants totaling more than $6 million.

Bert Vogelstein, M.D., whose published studies of cancer genetics are the most highly cited works in the field, received this year’s American Society of Clinical Oncology “Science of Oncology” Award at the group’s annual meeting in Orland, Fla., on June 1.

The Baltimore Sun’s Health and Science Reporter Stephanie Desmon, author of an acclaimed six-part series about breast cancer clinical trials volunteers, will speak about the critical role of clinical medical trials at CISCRP’s AWARE for All program in Baltimore on May 9, 2009.

One cell…one initial set of genetic changes – that’s all it takes to begin a series of events that lead to metastatic cancer.  Now, Johns Hopkins experts have tracked how the cancer process began in 33 men with prostate cancer who died of the disease.  Culling information from autopsies, their study points to a set of genetic defects in a single cell that are different for each person’s cancer.

Annual scratch-off game benefitting children’s cancer research began on April 9, 2009

A buildup of chemical bonds on certain cancer-promoting genes, a process known as hypermethylation, is widely known to render cells cancerous by disrupting biological brakes on runaway growth.  Now, Johns Hopkins scientists say the reverse process — demethylation — which wipes off those chemical bonds may also trigger more than half of all cancers.

LAB-ON-A-CHIP HOMES IN ON HOW CANCER CELLS BREAK FREE

Scientists at the Sol Goldman Pancreatic Cancer Research Center at the Johns Hopkins Kimmel Cancer Center have used "personalized genome" sequencing on an individual with a hereditary form of pancreatic cancer to locate a mutation in a gene called PALB2 that is responsible for initiating the disease.

Scientists at the Johns Hopkins Kimmel Cancer Center and Duke University Medical Center have linked mutations in two genes, IDH1 and IDH2, to nearly three-quarters of several of the most common types of brain cancers known as gliomas. Among the findings: people with certain tumors that carry these genetic alterations appear to
survive at least twice as long as those without them.